EUVIMEDEUVIMED entdecken
Crossref

Photo‐Controlled MUC1 Ablation via Steric Locking of Turn‐On Reactors Enhances Pyroptosis‐Immunotherapy of Triple Negative Breast Cancer

Huocheng Yang, Yingqi Liu, Menghuan Li, Xiaodong Zhang, Yanli Zhao iD, Zhong Luo

Advanced Materials · 2026-02 · 38 (7)

DOI: 10.1002/adma.202504460 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 17.11.2025. Verfasst von Huocheng Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Chongqing University, Chongqing, 400044, P. R. China. Hauptthemen laut MEDLINE: Mucin-1, Triple Negative Breast Neoplasms, Pyroptosis, Immunotherapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Graduate Research and Innovation Foundation of Chongqing, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucin 1 (MUC1) is aberrantly upregulated in triple‐negative breast cancer (TNBC) cells and presents major roles in orchestrating TNBC pathogenesis and therapeutic resistance. Herein, a bioorthogonal MUC1‐binding strategy is reported to install MUC1‐lockable aggregation‐induced emission theranostic reactor (AIETR) onto MUC1 for pyroptosis‐immunotherapy while enabling in situ MUC1 visualization. TNBC‐bearing hosts are first treated with 1,3,4‐O‐acetyl‐N‐azidoacetylmannosamine‐containing bioresponsive nanoassemblies to generate azido groups on MUC1 via sialic acid metabolism pathway. Dibenzocyclooctyne and MUC1‐binding aptamer arms in AIETR can separately bind with azide moieties and aptamer binding domains in MUC1 of glycoengineered TNBC cells and restrict intramolecular rotation to activate their AIE‐dependent reactive oxygen species (ROS) generation and fluorescence imaging capacity. The proximity‐dependent ROS damage abolishes membrane MUC1 to activate pyroptosis cascades. Moreover, treatment‐enabled MUC1 inactivation also ameliorates MUC1‐dependent immunosuppression in TNBC microenvironment to boost anti‐TNBC immunity. This study offers an effective approach for precision TNBC theranostics in the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucin-1Triple Negative Breast NeoplasmsPyroptosisImmunotherapyHumansCell Line, TumorAnimalsReactive Oxygen SpeciesFemaleMiceTheranostic Nanomedicine

Stichwörter der Autor:innen

aptamermucin 1pyroptosis immunotherapysialic acid glycoengineeringtheranostic reactor

Substanzen

Mucin-1Reactive Oxygen SpeciesMUC1 protein, human

Autor:innen und Institutionen

  • School of Life Science, Chongqing University, Chongqing, 400044, P. R. China.
  • School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, 637371, Singapore.

ORCID-Profile: Yanli Zhao

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Graduate Research and Innovation Foundation of Chongqing, China
  • Fundamental Research Funds for the Central Universities
  • National Research Foundation Singapore under Its Competitive Research Programme
  • Chongqing Science and Technology Commission
  • National Key Research and Development Program of China

Zitieren

APA

Yang, H., Liu, Y., Li, M., Zhang, X., Zhao, Y., & Luo, Z. (2026). Photo‐Controlled MUC1 Ablation via Steric Locking of Turn‐On Reactors Enhances Pyroptosis‐Immunotherapy of Triple Negative Breast Cancer. Advanced Materials, 38(7). https://doi.org/10.1002/adma.202504460

Vancouver

Yang H, Liu Y, Li M, Zhang X, Zhao Y, Luo Z. Photo‐Controlled MUC1 Ablation via Steric Locking of Turn‐On Reactors Enhances Pyroptosis‐Immunotherapy of Triple Negative Breast Cancer. Advanced Materials. 2026;38(7). doi:10.1002/adma.202504460

BibTeX
@article{Yang2026,
  author = {Yang, Huocheng and Liu, Yingqi and Li, Menghuan and Zhang, Xiaodong and Zhao, Yanli and Luo, Zhong},
  title = {Photo‐Controlled MUC1 Ablation via Steric Locking of Turn‐On Reactors Enhances Pyroptosis‐Immunotherapy of Triple Negative Breast Cancer},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {7},
  doi = {10.1002/adma.202504460}
}
Kostenlos starten →